BSE: 500422 | NSE: TRANSCHEM | Agriculture | Small Cap
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | |||
| ROCE % ⓘ | -1.7% | -1.3% | -1.6% | 0.3% | -2.9% | -3.4% | -4.9% | 0.4% | 1.1% | 48.5% | - | ||
| Value Creation Index ⓘ | -1.1 | -1.1 | -1.1 | -1.0 | -1.2 | -1.2 | -1.4 | -1.0 | -0.9 | 2.5 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.5 | 0 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| Adj EPS ⓘ | -0.7 | -0.6 | -0.6 | 0.1 | -0.9 | -1.1 | -1.5 | 0.1 | 0.3 | 19.7 | 2.3 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | -1010% | NA | NA | NA | 135.7% | 5878.8% | - | ||
| BVPS (₹) ⓘ | 33 | 31.9 | 31.2 | 31.3 | 31.4 | 31 | 30.1 | 31 | 30 | 51.4 | 51.4 | ||
| Adj Net Profit ⓘ | -0.9 | -0.7 | -0.7 | 0.1 | -1.1 | -1.3 | -1.8 | 0.2 | 0.4 | 24.2 | 3 | ||
| Cash Flow from Ops. ⓘ | 1.2 | 1.8 | 0.6 | 0.9 | 1.1 | 0.6 | -19.8 | 10.3 | -0.6 | -27.7 | - | ||
| Debt/CF from Ops. ⓘ | 2.6 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | NA | NA | NA | NA | ||||||||
| Adj EPS ⓘ | NA | NA | NA | 5878.8% | ||||||||
| BVPS ⓘ | 5.1 | 10.4 | 19.6 | 71.2 | ||||||||
| Share Price | 6.7% | 10.2% | 1.8% | 43.6% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | ||
| Return on Equity % ⓘ | -2.2 | -1.8 | -1.8 | 0.3 | -2.9 | -3.4 | -4.9 | 0.4 | 1.1 | 48.5 | 4.5 | |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91.4 | 0 | |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107.5 | 0 | |
| Debt to Equity ⓘ | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 457 | 0 | |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
No data to display
Return on Equity has declined versus last 3 years average to 4.50%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 2.3 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 51.4 | - |
| Reserves (₹ Cr.) ⓘ | 51 | - |
| P/BV ⓘ | 0.53 | - |
| PE ⓘ | 11.92 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 14.80 / 35.50 |
| All Time Low / High (₹) | 2.55 / 95.00 |
| Market Cap (₹ Cr.) | 33.5 |
| Equity (₹ Cr.) | 12.2 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 16.6 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.
The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.
The company is having four state of the art GMP approved facilities at multiple locations in
The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.
Products and services offered by the company:
Services:
Product:
Anthelmintics
Veterinary API's
Ectoparaciticides
Human Use API's
My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
